Glaukos (GKOS)
Develops implantable glaucoma therapies and corneal cross-linking treatments.
$157.48
vs last close−2.38 (−1.49%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
−$0.12
Revenue estimate
$167.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported−$0.40−$0.22−$0.24−$0.16−$0.28−$0.18−$0.14Pending
Estimate−$0.38−$0.33−$0.26−$0.27−$0.22−$0.30−$0.21−$0.12
Surprise−5.3%+33.3%+7.7%+40.7%−27.3%+40.0%+33.5%—
RevenueReportedEstimate
Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26Nov '26
Reported$105.5M$106.7M$124.1M$133.5M$143.1M$150.6M$185.6MPending
Estimate$101.0M$102.8M$122.4M$129.5M$136.4M$137.0M$150.9M$167.9M
Surprise+4.5%+3.8%+1.4%+3.2%+4.9%+9.9%+23.0%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.40 | — | — |
| Sep 2028 | $0.31 | — | — |
| Jun 2028 | $0.29 | — | — |
| Mar 2028 | $0.21 | — | — |
| Dec 2027 | $0.18 | — | — |
| Sep 2027 | $0.12 | — | — |
| Jun 2027 | $0.09 | — | — |
| Mar 2027 | $0.02 | — | — |
| Dec 2026 | $0.13 | — | — |
| Nov 2026 | −$0.12 | — | — |
| Jul 2026 | −$0.21 | −$0.14 | +33.5% |
| Apr 2026 | −$0.30 | −$0.18 | +40.0% |
| Feb 2026 | −$0.22 | −$0.28 | −27.3% |
| Oct 2025 | −$0.27 | −$0.16 | +40.7% |
| Jul 2025 | |||
| Apr 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Jul 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.40 | — | — | $282.9M | — | — | — |
| Sep 2028 | $0.31 | — | — | $243.2M | — | — | — |
| Jun 2028 | $0.29 | — | — | $278.5M | — | — | — |
| Mar 2028 | $0.21 | — | — | $219.8M | — | — | — |
| Dec 2027 | $0.18 | — | — | $227.8M | — | — | — |
| Sep 2027 | $0.12 | — | — | $204.1M | — | — | — |
| Jun 2027 | $0.09 | — | — | $214.9M | — | — | — |
| Mar 2027 | $0.02 | — | — | $186.8M | — | — | — |
| Dec 2026 | $0.13 | — | — | $187.0M | — | — | — |
| Nov 4, 2026 | −$0.12 | — | — | $167.9M | — | — | — |
| Jul 29, 2026 | −$0.21 | −$0.14 | +33.5% | $150.9M | $185.6M | +23.0% | +4.2% |
| Apr 29, 2026 | −$0.30 | −$0.18 | +40.0% | $137.0M | $150.6M | +9.9% | +22.8% |
| Feb 17, 2026 | −$0.22 | −$0.28 | −27.3% | $136.4M | $143.1M | +4.9% | +13.5% |
| Oct 29, 2025 | −$0.27 | −$0.16 | +40.7% | $129.5M | $133.5M | +3.2% | +13.9% |
| Jul 30, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Feb 20, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Jul 31, 2024 | |||||||
| May 1, 2024 | |||||||
| Feb 21, 2024 | |||||||
| Nov 1, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 3, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 22, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 27, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 8, 2019 | |||||||
| Feb 27, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 2, 2018 | |||||||
| May 9, 2018 | |||||||
| Feb 28, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 2, 2017 | |||||||
| May 3, 2017 | |||||||
| Mar 1, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 1, 2016 | |||||||
| May 3, 2016 | |||||||
| Mar 1, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 12, 2015 |